Skip to content

Medical Marijuana and Cancer

Medical Marijuana and Cancer

September is dedicated to recognizing numerous cancers that many around the world suffer from, including prostate, thyroid, ovarian and blood cancers. These cancers and many others can produce life-debilitating symptoms and conditions that are difficult to treat with traditional medications. Although there might not be one ‘perfect fix’ when it comes to curing cancer, medical marijuana is one that has brought several patients great relief when compared to other pharmaceutical options.

Chemotherapy-Induced Nausea and Vomiting

Intense nausea and vomiting are both common side effects of chemotherapy. Thankfully, in some cases, the active compound of marijuana, THC, has helped control nausea and increase a patient’s appetite. Two cannabinoid medications, dronabinol and nabilone, can be given to treat nausea and vomiting caused

by chemotherapy in patients who have not responded to standard antiemetic therapy. Clinical trials conducted on these two cannabis-derived medications have shown that both work just as well, if not better, than other nausea relieving medications. 

Neuropathy

Similar to nausea, neuropathy is a known complication of chemotherapy. The most common symptoms reported by cancer patients are weakness, numbness and tingling or burning in the hands and feet. According to studies on neuropathy and marijuana, cannabinoids could be effective in peripheral neuropathy, although there is yet to be a sufficient amount of studies conducted on chemotherapy-induced neuropathy. The hope is that medical cannabis could have the same or better effect on chemotherapy-induced neuropathy as it does on peripheral neuropathy.

Pain Relief

Most commonly, medical marijuana is known to help treat the qualifying condition of chronic pain. Cannabis can work in a patient’s treatment plan similarly to opioids, but on a much safer and less addictive level. This same treatment plan can directly be applied to those suffering from cancer and cancer-related pain. Medical cannabis has been observed to have anti-inflammatory effects, which can help with the relief of pain. Additionally, in some studies conducted on cancer patients experiencing pain from treatment, marijuana has been found to relieve the highest amount of pain when paired with opioids.

As with most conditions, there is still a multitude of research to be done on the full effects and benefits that medical marijuana can bring for cancer patients. With Arfinn Med, we are striving to bridge the educational gap by providing medical professionals a platform to store case file data and collaborate with peers across the country to help determine the best treatment plan for their patients. Are you ready to start treating your patients with the power of data? Register today! 

Sources: 

https://www.cancer.gov/about-cancer/treatment/cam/patient/cannabis-pdq

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/

https://www.ncbi.nlm.nih.gov/books/NBK224387/

https://www.lungcancer.org/find_information/publications/328-medical_marijuana_and_cancer

Stories you may be interested in

Data Migration During EMR Changes

One of the most challenging aspects when deciding to switch to a new EMR system is how to get existing data from the old system to the new system safely, securely and accurately.  Many times, the scope of this task is enough to force providers to remain with a subpar vendor even though there are…
Read More

REGISTRATION NOW OPEN: Arfinn Med Medical Cannabis Efficacy Portal for Licensed Medical Professionals

Arfinn Med, the first clinician-based medical professional and patient efficacy portal for medical cannabis treatments, is now open for registrations from licensed medical professionals. The free collaborative portal allows medical professionals to register, share, research and communicate HIPAA-compliant benchmark data for medical cannabis treatments. As a free tool for physicians, Arfinn Med offers a new…
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More

Dr. Sanjay Gupta on medical marijuana: We are in an age of wisdom, but also an age of foolishness

When we released “Weed” in 2013, few people had ever heard of cannabidiol, or CBD. Now, two-thirds of Americans are familiar with the compound, and 1 in 7 have tried it. Most of the country, 93%, are in favor of medical marijuana and hemp-derived CBD itself, which has less than 0.3% THC, has been legalized in every state.It’s…
Read More

The Lack of Clinical Trials in the Medical Marijuana Industry

As time goes on, medical marijuana is starting to break barriers in various states across the country. Out of the 50 states, 33 have approved a comprehensive medical marijuana program (NCSL). Currently, marijuana, medical or recreational, is illegal at the federal level, despite legalization in various states. Many medical professionals are interested in prescribing medical…
Read More

New Feature: Text Message Treatment Updates

New to the Arfinn Med portal comes the ability to receive real time updates from patients via text messaging. This new addition will allow physicians to stay up to date on current patient efficacies as well as streamline the data collection process. Through the new text messaging function, physicians are able to send patients automated…
Read More

Leave a Comment

You must be logged in to post a comment.